Updates

UMUC Master of Science in Cybersecurity Policy

University of Maryland University College (UMUC) offers a Master of Science in Cybersecurity Policy designed for midcareer professionals who are interested in meeting the challenges posed by increasing cyber threats. Using a multidisciplinary approach, the program is designed to provide students with a broad analytical framework for evaluating and solving cybersecurity problems.

NIH Awards Seven New Vaccine Adjuvant Discovery Contracts

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability.

HHS Funds Drug to Treat Severe Infections & Prevent Cytokine Storm

An agreement announced by the U.S. Department of Health and Human Services will advance development of a drug that could potentially combat cytokine storm, which is a complication caused by severe infections. This drug therapy modulates inflammatory response and may help treat flesh-eating bacteria and injuries caused by bioagents.

FEMA Awards $11 Million to Increase Preparedness Through the Continuing Training Grants Program

The Department of Homeland Security's Federal Emergency Management Agency (FEMA) recently awarded six training grants totaling $11 million for the 2014 Continuing Training Grant (CTG) program. These awards will help train and certify members of the whole community - including first responders, emergency managers, technical specialists, community leaders, and tribal and local governments.

New MSA PrimaX IR Combustible Gas Monitor for Reliable Performance in Extreme Conditions

MSAs SIL 2-certified PrimaX IR Combustible Gas Monitor offers superior performance by withstanding the most challenging environmental conditions and maximizing optics to provide maximum signal and extraordinary stability.

Updates to FirstDefender RM/RMX Instruments Improve Chemical Identification Capabilities

The Thermo Scientific FirstDefender RM/RMX v4.2 software update adds more than 400 new chemicals to the instruments library, including those on the European Unions REACH Chemical List and additional explosive precursors, steroids, and narcotics.

FDA Releases Updated Proposals to Improve Food Safety and Help Prevent Foodborne Illness

Based on extensive outreach and public comment, the U.S. Food and Drug Administration (FDA) proposed revisions to four rules designed to help prevent foodborne illness. Once finalized, the rules will implement portions of the FDA Food Safety Modernization Act, which aims to strengthen food safety by shifting the focus to preventing food-safety problems rather than responding to them.

CBP Discusses Preclearance Expansion With Industry

U.S. Customs and Border Protection (CBP) Acting Deputy Commissioner Kevin K. McAleenan addressed the World Routes Strategy Summit in Chicago, Illinois, regarding Preclearance Expansion. CBPs preclearance operations are an important step in the U.S. governments effort to prevent terrorism from coming to our borders, said McAleenan.

RST Thermally Conductive Demron Offers Unique Protection in the Treatment & Transportation of Ebola Victims

RSTs Demron chemical, biological, radiological, and nuclear (CBRN) suits offer unique capabilities in the war against Ebola Virus Disease. Because of Demrons patented thermal conductive capabilities, Ebola healthcare workers wearing the suits can be monitored externally for the onset of fever, one of the first signs of the disease.

FACT SHEET: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria

The executive order, signed by President Barack Obama, directs federal departments and agencies to implement the National Strategy, a five-year plan for enhancing domestic and international capacity to: prevent and contain outbreaks of antibiotic-resistant infections; maintain the efficacy of current and new antibiotics; and develop and deploy next-generation diagnostics, antibiotics, vaccines, and other therapeutics.